Par Drugs and Chemicals vs Peers
- Market cap
- ₹145 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹84.78 – ₹158.96
Par Drugs and Chemicals ranks 1st by market capitalisation among 1 Drug Manufacturers - Specialty & Generic companies tracked by ATS. Its largest peers are Par Drugs and Chemicals. Its P/E of 22.5 compares with a peer median of 22.5.
Par Drugs and Chemicals vs Drug Manufacturers - Specialty & Generic peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Par Drugs and Chemicals | 117.75 | -6.01% | 145 | 22.5 | 2.85 | 14.5% | +18.5% |
| Par Drugs and Chemicals | 117.75 | -6.01% | 145 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Par Drugs and Chemicals peer comparison — frequently asked questions
Who are Par Drugs and Chemicals' competitors?
Par Drugs and Chemicals' listed peers in Drug Manufacturers - Specialty & Generic include Par Drugs and Chemicals, ranked here by market capitalisation.
How does Par Drugs and Chemicals' P/E compare with its peers?
Par Drugs and Chemicals trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - Specialty & Generic peers shown.
Which is the largest company among Par Drugs and Chemicals' peers?
By market capitalisation, the largest company in the group is Par Drugs and Chemicals at ₹145 crore, against ₹145 crore for Par Drugs and Chemicals.
Same Data For Peers
Trade Par Drugs and Chemicals With ATS
Track PAR live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.